The role focuses on novel targeted oncology therapies including Radio Conjugates, Antibody Drug Conjugates (ADCs), and Small Molecules to accelerate transformative patient therapies
Job Summary
The role focuses on novel targeted oncology therapies including Radio Conjugates, Antibody Drug Conjugates (ADCs), and Small Molecules to accelerate transformative patient therapies.
Candidates will lead regulatory and investigative toxicology study design while applying expertise to predict clinical safety risks and support data-driven decisions across discovery and development programs.
AstraZeneca offers a competitive annual base salary ranging from $178,540.80 to $267,811.20 USD along with short-term incentives, equity-based long-term programs, and comprehensive health benefits.
Matching Summary
The role focuses on novel targeted oncology therapies including Radio Conjugates, Antibody Drug Conjugates (ADCs), and Small Molecules to accelerate transformative patient therapies.
Salary
Base: $178,540.80 - $267,811.20 USD Annual; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program available; Benefits: Qualified retirement program (401k), paid vacation/holidays, leaves, medical, dental, vision coverage
Skills & Requirements
Must-have
Project Toxicology experience
Investigative Toxicology expertise
Oncology drug development knowledge
IND filing support capability
In vitro in silico in vivo tools
Nice-to-have
Radio Conjugate modality expertise
Antibody Drug Conjugates (ADCs) familiarity
Organ-on-chip and omics technologies
Cross-functional collaboration skills
Thought leadership in publications
Key Requirements
PhD and/or DABT in Toxicology or related field
10+ years experience in Project or Investigative Toxicology
Proven ability to deliver toxicology programs supporting IND filings